Peloton Therapeutics Raises $18M

Dallas-based Peloton Therapeutics, an early stage cancer drug discovery and development startup, said today that it has raised $18M in a Series A financing round. The round was led by The Column Group, and also included Remeditex Ventures and Peter O'Donnell, Jr. Peloton is focused on oncology programs, and is partnered with the University of Texas Southwestern Medical Center. The firm was founded by Steven L. McKnight, Ph.D. More information »